Galderma, a global dermatology company, has announced the expansion of its premium regenerative skincare brand, Alastin, across key markets in the Japan and Asia Pacific (JPAC) region. The rollout marks another step in the company’s regional growth strategy as demand for advanced skincare and aesthetic treatments continues to rise.
Alastin has recently been introduced in Taiwan and is set to launch in Japan shortly. The brand has also received regulatory approval in Singapore and South Korea, where commercial launches are planned for September and November, respectively. The latest expansion follows successful introductions in China and Australia, strengthening Galderma’s presence across some of the region’s fastest-growing skincare and medical aesthetics markets.
The company said the expansion is aimed at meeting the increasing demand for skincare solutions that support skin preparation, recovery and long-term skin health alongside aesthetic procedures. As the popularity of injectable treatments and energy-based devices continues to grow across Asia Pacific, healthcare professionals and consumers are seeking products that complement these procedures and improve overall skin quality.
Alastin’s product portfolio is designed to support the skin’s natural regenerative processes before and after aesthetic treatments, while also providing solutions for everyday skincare. Several products are powered by the company’s proprietary TriHex Technology®, which combines peptide-based ingredients that help remove damaged collagen and elastin while supporting the formation of new, healthy collagen and elastin. The latest Restorative Skin Complex with TriHex+â„¢ also promotes the skin’s natural production of high molecular weight hyaluronic acid, contributing to improved hydration, elasticity and long-term skin health.
Dr Rieko Tsubouchi, Dermatologist and Director of Ginza Skin Clinic in Japan, said patients are increasingly looking for skincare that delivers more than hydration. She noted that Alastin supports the skin’s natural regenerative capacity, complements aesthetic procedures and helps patients achieve healthier, stronger and more radiant skin.
The Alastin portfolio being introduced in the JPAC region includes nine products covering procedure support, targeted treatment and daily skincare. These include Skin Nectar and INhance for use before and after aesthetic procedures, restorative products for the face, neck and eye area, brightening and antioxidant serums, hydration solutions, and a nourishing daily moisturizer.
Alan D Widgerow, Chief Scientific Officer and Head of Innovation for Dermatological Skincare at Galderma, said the regional launch reinforces the company’s commitment to providing integrated skincare solutions that work alongside its injectable aesthetics portfolio. He added that Alastin enables healthcare professionals to offer personalized skincare throughout the aesthetic treatment journey.
Backed by more than 60 international dermatology publications and over 25 granted patents, Alastin is among the most extensively researched professional skincare brands. The company says the products have demonstrated strong clinical performance in improving skin recovery, hydration, resilience and overall appearance.
Galderma currently operates in around 90 countries and offers a broad portfolio spanning injectable aesthetics, dermatological skincare and therapeutic dermatology. With the expansion of Alastin across Japan and other Asia Pacific markets, the company aims to strengthen its regenerative skincare offering and address evolving consumer needs related to skin quality, healthy ageing and long-term skin wellness.
Backed by more than 60 international dermatology publications and over 25 granted patents, Alastin is among the most extensively researched professional skincare brands. The company says the products have demonstrated strong clinical performance in improving skin recovery, hydration, resilience and overall appearance.
Galderma currently operates in around 90 countries and offers a broad portfolio spanning injectable aesthetics, dermatological skincare and therapeutic dermatology. With the expansion of Alastin across Japan and other Asia Pacific markets, the company aims to strengthen its regenerative skincare offering and address evolving consumer needs related to skin quality, healthy ageing and long-term skin wellness.